Name | Number of supported studies | Average coverage | |
---|---|---|---|
transit amplifying cell | 3 studies | 25% ± 5% |
Insufficient scRNA-seq data for expression of ARHGAP11A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 192.76 | 21 / 21 | 91% | 11.41 | 461 / 504 |
intestine | 93% | 398.81 | 899 / 966 | 95% | 14.15 | 502 / 527 |
esophagus | 86% | 452.52 | 1248 / 1445 | 100% | 20.58 | 183 / 183 |
skin | 100% | 1703.74 | 1806 / 1809 | 86% | 9.68 | 406 / 472 |
lung | 97% | 298.30 | 558 / 578 | 86% | 10.75 | 997 / 1155 |
stomach | 84% | 269.50 | 303 / 359 | 96% | 14.59 | 274 / 286 |
breast | 92% | 171.46 | 423 / 459 | 87% | 9.29 | 970 / 1118 |
pancreas | 98% | 282.35 | 320 / 328 | 76% | 5.22 | 135 / 178 |
uterus | 62% | 84.16 | 105 / 170 | 98% | 17.08 | 448 / 459 |
ovary | 56% | 88.61 | 100 / 180 | 92% | 8.67 | 394 / 430 |
brain | 79% | 185.33 | 2096 / 2642 | 46% | 4.08 | 322 / 705 |
thymus | 92% | 163.12 | 598 / 653 | 20% | 2.49 | 119 / 605 |
adrenal gland | 84% | 198.92 | 218 / 258 | 27% | 1.82 | 61 / 230 |
prostate | 86% | 153.04 | 211 / 245 | 15% | 0.76 | 73 / 502 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.60 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.23 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.33 | 1 / 1 |
spleen | 100% | 511.81 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 95% | 204.14 | 1149 / 1204 | 0% | 0 | 0 / 0 |
liver | 39% | 87.18 | 89 / 226 | 41% | 2.70 | 165 / 406 |
blood vessel | 78% | 144.11 | 1045 / 1335 | 0% | 0 | 0 / 0 |
kidney | 44% | 83.93 | 39 / 89 | 24% | 1.27 | 214 / 901 |
peripheral blood | 64% | 1306.37 | 598 / 929 | 0% | 0 | 0 / 0 |
heart | 49% | 73.97 | 422 / 861 | 0% | 0 | 0 / 0 |
muscle | 43% | 57.19 | 342 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 14% | 0.52 | 11 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | ARHGAP11A |
Protein name | Rho GTPase activating protein 11A Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A) ARHGAP11A |
Synonyms | KIAA0013 |
Description | FUNCTION: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. . |
Accessions | ENST00000543522.5 [Q6P4F7-3] ENST00000619401.4 [Q6P4F7-1] A0A2X0SFK9 ENST00000562481.1 ENST00000565905.5 [Q6P4F7-3] ENST00000567348.5 [Q6P4F7-2] H3BQ41 H3BR51 ENST00000563864.5 Q6P4F7 ENST00000611363.1 [Q6P4F7-3] ENST00000361627.8 [Q6P4F7-1] ENST00000622253.4 [Q6P4F7-3] |